Can the foreign entity be the applicant for information backup and filing? | BradyKnows

Subscribe

No, it should be applied by the Chinese data information owner.

Suggested Reading

How should the evaluation of new items in the endpoint table be considered after the implementation of the new…
What are the key focus areas in the evaluation of acute, subacute, subchronic, and chronic toxicity, and can…
Under what conditions can the extraction liquid of dressings be accepted after pH adjustment, centrifugation,…
What factors may affect biocompatibility risk when using biological test data from similar devices for…
Can products made from materials conforming to YY 0341.1 Appendix B be exempted from biological evaluation?
GB/T 16886.1-2022 includes implantation in the biological evaluation of dressings. How should implantation tests…
For subchronic systemic toxicity studied via implantation, what is the basis for determining the implantation…
When combining subchronic and implantation tests in one project, what factors need to be considered, and how can…
Do all medical devices require chemical characterization?
How is the endotoxin limit for wound dressing products determined?
GB/T 16886.11-2021 adds tests for subchronic systemic toxicity evaluation with dual-route exposure. Which…
Why is the extraction period typically 24 hours in China for cytotoxicity testing?

Previous: Can the end time of external provision of information backup and filing be later than the deadline of international cooperation?

Next: When should do information back up and filing in case of the published articles that involve the open use of human genetic resources information?